Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Oman Medical Journal. 2013; 28 (4): 255-259
em Inglês | IMEMR | ID: emr-130320

RESUMO

To assess the efficacy and safety of extracorporeal shock wave lithotripsy with Modularis Vario Siemens in the management of patients with renal and ureteral stones. Between 2007 and 2009, 225 outpatients were treated with Siemens Modularis Vario lithotripter at Sultan Qaboos University Hospital. Stone size, location, total number of shockwaves, stone-free rate, complications and adjunctive interventions were investigated. Chi-Square and Logistic Regression analyses were used, with p<0.05 set as the level of significance. Of the 225 initial consecutive patients who underwent extracorporeal shock wave lithotripsy, 192 [85%] had renal stones and 33 [15%] had ureteric stones. The mean +/- SD stone size was 11.3 +/- 4.5 mm, while the mean age of the patients was 39.9 +/- 12.8 years with 68.5% males. The mean renal stone size was 11.6 +/- 4.7 mm; a mean of 1.3 sessions was required. The mean ureteric stone size was 9.9 +/- 3 mm; and a mean of 1.3 sessions was required. Treatment success [defined as complete clearance of ureteric stones, stone-free or clinically insignificant residual fragments of <4 mm for renal stones] was 74% for renal stones and 88% for ureteric stones. Additional extracorporeal shock wave lithotripsy and ureteroscopy were the most adjunctive procedures used for stone clearance. Complications occurred in 74 patients [38.5%] with renal stones and 13 patients [39.4%] with uretetric stones. The most common complication was loin pain [experienced by 16.7% with renal stones and 21% with ureteric stones]. Severe renal colic mandating admission occurred in 2% of patients with renal stones and 6% of patients with ureteric stones. In patients with renal stone, steinstrasse occurred in 3.6% and infection post extracorporeal shock wave lithotripsy in 0.5%. Using Multivariate Logistic Regression analysis, factors found to have significant effect on complete stone clearance were serum creatinine [p=0.004] and the number of shockwaves [p=0.021]. Siemens Modularis Vario lithotripter is a safe and effective tool for treating renal and ureteric stones


Assuntos
Humanos , Feminino , Masculino , Resultado do Tratamento , Cálculos Renais/terapia , Ureter
2.
SQUMJ-Sultan Qaboos University Medical Journal. 2010; 10 (3): 350-353
em Inglês | IMEMR | ID: emr-143780

RESUMO

The objectives of this study were to compare the demographics, semen parameters and hormone profiles in men with primary and secondary infertility. The study was designed as a retrospective analysis of data collected from men attending a combined infertility clinic [seen together by urologist and gynaecologist] from January 2005 to December 2008 at Sultan Qaboos University Hospital, a tertiary care hospital in Oman. Ninety-eight consecutive male patients with one or more abnormalities in semen analysis were referred to the combined infertility clinic. A complete physical examination was carried out by a urologist followed by hormone evaluation of follicle stimulating hormone [FSH], luteinizing hormone [LH], testosterone [T] and prolactin [PRL]. The semen parameters and the sex hormone evaluation were not significantly different between the men with primary and secondary infertility. The men with primary infertility were younger than the men with secondary infertility. A total of 24% of the men in the primary group and 16% in the secondary group were azoospermic with normal gonadotropin values in 9 men and 1 man in the primary and secondary group respectively. Azoospermia was more common in the primary infertile group and, based on gonadotropin levels, obstructive causes seemed more prevalent in the primary group compared to secondary group


Assuntos
Humanos , Masculino , Infertilidade Masculina/diagnóstico , Sêmen , Espermatozoides , Azoospermia , Demografia , Testosterona , Hormônio Foliculoestimulante , Hormônio Luteinizante , Prolactina
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA